CollPlant Biotechnologies (CLGN) Shares Outstanding (Diluted Average) (2019 - 2025)

CollPlant Biotechnologies' Shares Outstanding (Diluted Average) history spans 7 years, with the latest figure at $12.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 6.54% year-over-year to $12.2 million; the TTM value through Dec 2025 reached $12.2 million, up 6.54%, while the annual FY2025 figure was $12.2 million, 6.54% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $12.2 million in Q4 2025 per CLGN's latest filing, up from $11.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $12.2 million in Q4 2025 to a low of $11.0 million in Q4 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $11.6 million, with a median of $11.5 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Diluted Average): skyrocketed 73.76% in 2021, then fell 7.8% in 2022.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $12.0 million in 2021, then fell by 7.8% to $11.0 million in 2022, then increased by 3.23% to $11.4 million in 2023, then increased by 0.57% to $11.5 million in 2024, then rose by 6.54% to $12.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Shares Outstanding (Diluted Average) are $12.2 million (Q4 2025), $11.5 million (Q4 2024), and $11.4 million (Q4 2023).